Btissame El Hassouni

Role of c-MET Inhibitors in Overcoming Drug Resistance in Spheroid Models of Primary Human Pancreatic Cancer and Stellate Cells

Omidreza Firuzi, Pei Pei, Btissame El Hassouni et al. · Cancers · 2019 · 74 citations · Full text

Tumor Biology, Pdac Cell Growth, Pancreatic Cancer +14

Proteomic analysis of gemcitabine-resistant pancreatic cancer cells reveals that microtubule-associated protein 2 upregulation associates with taxane treatment

Tessa Y. S. Le Large, Btissame El Hassouni, Niccola Funel et al. · Therapeutic Advances in Medical Oncology · 2019 · 68 citations · Full text

Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma

Rocco Sciarrillo, Anna Wojtuszkiewicz, Btissame El Hassouni et al. · EBioMedicine · 2018 · 64 citations · Full text

Medicine, Immunology, Pathology +6

3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pancreatic Ductal Adenocarcinoma

Stella Cascioferro, Giovanna Li Petri, Barbara Parrino et al. · Molecules · 2020 · 53 citations · Full text

Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma

Tessa Y. S. Le Large, Maarten F. Bijlsma, Btissame El Hassouni et al. · Journal of Experimental & Clinical Cancer Research · 2021 · 53 citations · Full text